Buyer Consortium Completes Privatization of ShangPharma
ShangPharma is a leading, China-based contract research organization.
The transaction is just the second private equity sponsor-backed going-private transaction of a China-based, NYSE or NASDAQ listed company to sign and close since the beginning of 2012.